AUSTIN, Texas - (Business Wire) SmallCapVoice.com, Inc. announced today that a new audio interview profiling the San Francisco California based company, Cannabis Science Inc. (NASD OTCBB: CBIS), an emerging pharmaceutical cannabis company, is now available. The interview can be heard at http://smallcapvoice.com/blog/3-24-09-audio-interview-with-cannabis- science-inc-otcbb-cbis/ SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its client’s financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and investor fact sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about Smallcapvoice.com and their services, please visit http://www.smallcapvoice.com/services.html.
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. It is dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Safe Harbor Statement: The Private Securities Litigation Reform Act of 1995 provides a “Safe Harbor” for forward-looking statements. Certain of the statements contained herein, which are not historical facts, are forward-looking statements with respect to events, the occurrence of which involves risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company’s reports filed with the Securities Exchange Commission.
Cannabis Science Inc.
Steven W. Kubby, 888-889-0888
President & CEO
info@cannabisscience.com
www.cannabisscience.com
or
Brokers and Analysts:
Wall Street International
John Campo, 1-410-236-8200
or
SmallCapVoice.com, Inc.
Stuart T. Smith, 512-267-2430
CEO & President
Info@smallcapvoice.com
